Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Peter Corry

Concepts (220)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperthermia, Induced
9
2012
108
1.380
Why?
Radiotherapy, Intensity-Modulated
6
2017
170
1.010
Why?
Antioxidants
2
2020
297
0.940
Why?
Radiotherapy Planning, Computer-Assisted
8
2017
245
0.870
Why?
Tomography, Spiral Computed
5
2017
56
0.770
Why?
Radiometry
6
2017
125
0.760
Why?
Abdomen
2
2011
84
0.750
Why?
Radiation-Protective Agents
3
2020
116
0.720
Why?
Heart
4
2013
361
0.650
Why?
Oxygen
3
2012
361
0.630
Why?
Radiotherapy, Image-Guided
3
2016
25
0.620
Why?
Neoplasms
7
2016
1322
0.610
Why?
Pneumonia, Viral
1
2020
184
0.580
Why?
Coronavirus Infections
1
2020
192
0.570
Why?
Organ Sparing Treatments
2
2016
54
0.540
Why?
Radiotherapy
3
2012
137
0.530
Why?
Mammary Neoplasms, Experimental
3
2012
135
0.510
Why?
Pandemics
1
2020
594
0.510
Why?
Organs at Risk
3
2016
70
0.470
Why?
Radiation Injuries, Experimental
2
2013
105
0.460
Why?
Head and Neck Neoplasms
3
2017
336
0.450
Why?
Galectin 1
1
2012
21
0.420
Why?
Radiation Injuries
3
2013
153
0.420
Why?
Blood Vessels
1
2012
78
0.410
Why?
Peptides
2
2012
276
0.400
Why?
Molecular Targeted Therapy
1
2012
128
0.400
Why?
Brain Neoplasms
2
2012
285
0.390
Why?
Radiosurgery
1
2012
122
0.380
Why?
Bone and Bones
2
2011
515
0.380
Why?
Myocardium
4
2014
443
0.370
Why?
Animals
19
2021
14409
0.360
Why?
Acetylcysteine
1
2010
118
0.360
Why?
Carcinoma, Squamous Cell
2
2012
385
0.350
Why?
Ultrasonic Therapy
2
2008
40
0.340
Why?
Image Processing, Computer-Assisted
3
2017
256
0.340
Why?
Cerebellar Neoplasms
2
2009
23
0.340
Why?
Cranial Irradiation
2
2009
24
0.340
Why?
Bone Density
1
2011
416
0.340
Why?
Medulloblastoma
1
2008
17
0.320
Why?
Oxygen Consumption
1
2009
223
0.310
Why?
Radiotherapy Dosage
7
2017
245
0.310
Why?
Mice
9
2021
6428
0.290
Why?
Combined Modality Therapy
6
2012
693
0.280
Why?
Radiobiology
1
2005
20
0.270
Why?
Heat-Shock Response
1
2005
29
0.270
Why?
Heat-Shock Proteins
1
2005
87
0.260
Why?
Whole-Body Irradiation
2
2020
161
0.260
Why?
Medicine
1
2005
58
0.260
Why?
Dose-Response Relationship, Radiation
4
2012
204
0.230
Why?
Brain
1
2012
1392
0.230
Why?
Radiation Dosage
3
2008
170
0.220
Why?
Radiotherapy, Conformal
2
2016
55
0.220
Why?
Tocotrienols
2
2013
42
0.220
Why?
High-Intensity Focused Ultrasound Ablation
2
2011
15
0.200
Why?
Rats
7
2021
3419
0.190
Why?
Angiogenesis Inhibitors
2
2012
203
0.180
Why?
Humans
21
2021
54391
0.180
Why?
Neovascularization, Pathologic
2
2012
168
0.180
Why?
Models, Biological
3
2016
825
0.170
Why?
Hot Temperature
3
2012
199
0.170
Why?
MicroRNAs
1
2021
386
0.150
Why?
Radiation Protection
2
2016
55
0.140
Why?
Cell Line, Tumor
4
2012
1551
0.130
Why?
Mice, Inbred C57BL
2
2011
2001
0.130
Why?
Phantoms, Imaging
3
2011
126
0.120
Why?
Equipment Design
2
2012
318
0.120
Why?
Pentoxifylline
1
2013
19
0.120
Why?
Immunohistochemistry
2
2013
1090
0.110
Why?
Monte Carlo Method
1
2013
99
0.110
Why?
Radiography
3
2009
526
0.110
Why?
Kininogens
1
2012
4
0.110
Why?
Kallikrein-Kinin System
1
2012
4
0.110
Why?
Ablation Techniques
1
2012
25
0.110
Why?
Prostatic Neoplasms
1
2017
421
0.110
Why?
Tumor Burden
2
2010
141
0.110
Why?
Radiation Tolerance
1
2013
87
0.110
Why?
Bystander Effect
1
2012
22
0.110
Why?
Time Factors
4
2014
3210
0.110
Why?
Cell Hypoxia
1
2012
87
0.100
Why?
Myocarditis
1
2012
45
0.100
Why?
Male
10
2021
27347
0.100
Why?
Models, Theoretical
1
2012
184
0.100
Why?
Computer Simulation
4
2016
332
0.100
Why?
Organ Specificity
1
2011
126
0.100
Why?
Cell Survival
2
2012
657
0.100
Why?
Cell Proliferation
2
2012
1097
0.100
Why?
Lung Neoplasms
1
2017
643
0.090
Why?
Leukocyte Count
1
2010
77
0.090
Why?
Malformations of Cortical Development
1
2009
4
0.090
Why?
Tubulin
1
2009
28
0.090
Why?
Mitochondria
1
2014
490
0.090
Why?
Optic Nerve Diseases
1
2009
27
0.090
Why?
Taxoids
1
2009
45
0.090
Why?
Radiation Pneumonitis
1
2009
9
0.090
Why?
Carboplatin
1
2009
63
0.090
Why?
Fluorouracil
1
2009
61
0.090
Why?
Disease Progression
1
2012
915
0.090
Why?
Spinal Neoplasms
1
2009
32
0.080
Why?
Body Weight
1
2011
578
0.080
Why?
Paclitaxel
1
2009
103
0.080
Why?
Necrosis
1
2009
208
0.080
Why?
Signal Transduction
2
2013
1752
0.080
Why?
History, 20th Century
1
2009
114
0.080
Why?
Microscopy, Fluorescence
1
2009
198
0.080
Why?
Osteogenesis
1
2011
377
0.080
Why?
Bone Marrow
1
2010
414
0.080
Why?
Weight Loss
1
2010
271
0.080
Why?
Radiotherapy, Computer-Assisted
1
2007
16
0.080
Why?
Reactive Oxygen Species
1
2010
491
0.080
Why?
Gene Expression Regulation, Neoplastic
1
2012
868
0.080
Why?
Skull
1
2007
79
0.080
Why?
Central Nervous System Neoplasms
1
2007
57
0.070
Why?
Cisplatin
1
2009
351
0.070
Why?
Follow-Up Studies
2
2009
2390
0.070
Why?
Spine
1
2007
112
0.070
Why?
Particle Accelerators
2
2017
50
0.070
Why?
Swine
3
2012
430
0.070
Why?
Rats, Sprague-Dawley
3
2014
1664
0.070
Why?
Cell Death
1
2005
223
0.060
Why?
Temperature
1
2005
177
0.060
Why?
Retrospective Studies
3
2012
6459
0.060
Why?
Treatment Outcome
2
2012
5612
0.060
Why?
Mitogen-Activated Protein Kinase 3
2
2013
55
0.060
Why?
Mitogen-Activated Protein Kinase 1
2
2013
55
0.060
Why?
Antigens, Differentiation, Myelomonocytic
2
2013
46
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2009
1060
0.060
Why?
Mutation
1
2009
1504
0.060
Why?
Cell Line
1
2005
1152
0.050
Why?
Ferrets
1
2021
6
0.050
Why?
Aged
2
2021
10060
0.050
Why?
Antigens, CD
2
2013
242
0.050
Why?
Cricetinae
1
2021
209
0.050
Why?
Glycolysis
1
2021
73
0.050
Why?
Phosphorylation
2
2013
613
0.050
Why?
ROC Curve
1
2021
259
0.050
Why?
Middle Aged
2
2021
13082
0.050
Why?
Antiviral Agents
1
2021
188
0.050
Why?
Adult
2
2021
14207
0.040
Why?
Rabbits
2
2010
425
0.040
Why?
Proteomics
1
2021
343
0.040
Why?
Gene Expression
2
2012
664
0.040
Why?
Female
6
2021
28471
0.040
Why?
Inflammation
1
2021
678
0.040
Why?
X-Rays
1
2016
57
0.040
Why?
Cone-Beam Computed Tomography
1
2016
34
0.040
Why?
Sensitivity and Specificity
2
2009
922
0.040
Why?
Gene Expression Regulation
1
2021
1063
0.030
Why?
Child, Preschool
3
2009
4158
0.030
Why?
Multiple Myeloma
1
2010
3049
0.030
Why?
Reproducibility of Results
2
2009
1301
0.030
Why?
Mitochondrial Membrane Transport Proteins
1
2014
23
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
48
0.030
Why?
Cell Respiration
1
2014
51
0.030
Why?
bcl-2-Associated X Protein
1
2014
73
0.030
Why?
Protein Kinase C-alpha
1
2013
11
0.030
Why?
Aged, 80 and over
1
2021
3431
0.030
Why?
Protein Conformation
1
2014
226
0.030
Why?
Software
1
2016
297
0.030
Why?
Mast Cells
1
2013
64
0.030
Why?
Cell Count
1
2013
181
0.030
Why?
Skin Temperature
1
2012
19
0.030
Why?
Proto-Oncogene Proteins c-bcl-2
1
2014
158
0.030
Why?
Drug Interactions
1
2013
206
0.030
Why?
Mitochondrial Swelling
1
2012
5
0.030
Why?
Rats, Inbred BN
1
2012
21
0.030
Why?
Receptor, Bradykinin B2
1
2012
9
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2013
176
0.030
Why?
Models, Animal
1
2013
255
0.030
Why?
Film Dosimetry
1
2012
15
0.030
Why?
Administration, Oral
1
2013
461
0.030
Why?
Up-Regulation
1
2014
509
0.030
Why?
MAP Kinase Signaling System
1
2012
133
0.030
Why?
Child
3
2009
7368
0.030
Why?
Neck
1
2012
116
0.030
Why?
Computer-Aided Design
1
2011
21
0.030
Why?
Equipment Failure Analysis
1
2011
49
0.030
Why?
Fibrosarcoma
1
2011
13
0.030
Why?
Partial Pressure
1
2011
17
0.020
Why?
Endothelial Cells
1
2013
294
0.020
Why?
Heart Ventricles
1
2013
271
0.020
Why?
Blotting, Western
1
2012
684
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
674
0.020
Why?
Burns
1
2012
170
0.020
Why?
Bone Transplantation
1
2010
55
0.020
Why?
Consanguinity
1
2009
15
0.020
Why?
Radiation-Sensitizing Agents
1
2010
55
0.020
Why?
Pakistan
1
2009
24
0.020
Why?
Genes, Recessive
1
2009
18
0.020
Why?
DNA Damage
1
2012
357
0.020
Why?
Feasibility Studies
1
2011
398
0.020
Why?
Nuclear Family
1
2009
14
0.020
Why?
Cell Transformation, Neoplastic
1
2011
200
0.020
Why?
Protein Transport
1
2010
195
0.020
Why?
Protein Isoforms
1
2009
124
0.020
Why?
Pedigree
1
2009
146
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2009
82
0.020
Why?
Leukemia, Myeloid, Acute
1
2011
192
0.020
Why?
Mammary Glands, Animal
1
2009
69
0.020
Why?
Syndrome
1
2009
253
0.020
Why?
Neoplasms, Experimental
1
2009
115
0.020
Why?
Base Sequence
1
2009
719
0.020
Why?
Genetic Variation
1
2009
253
0.020
Why?
Metals
1
2008
44
0.020
Why?
Acute Disease
1
2009
403
0.020
Why?
Molecular Sequence Data
1
2009
980
0.020
Why?
Apoptosis
1
2014
1302
0.020
Why?
Lung
1
2011
508
0.020
Why?
Algorithms
1
2011
697
0.020
Why?
Proteins
1
2010
376
0.020
Why?
Breast Neoplasms
1
2016
1249
0.020
Why?
Polymorphism, Single Nucleotide
1
2009
552
0.020
Why?
Oxidative Stress
1
2012
958
0.020
Why?
Survival Rate
1
2009
954
0.020
Why?
Adolescent
2
2009
6900
0.020
Why?
Skin
1
2009
469
0.020
Why?
Kidney
1
2011
822
0.020
Why?
Severity of Illness Index
1
2009
1082
0.020
Why?
Liver
1
2011
1226
0.020
Why?
Tomography, X-Ray Computed
1
2008
1222
0.010
Why?
Young Adult
1
2009
4318
0.010
Why?
Corry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description